Francisco José Miranda Rodrigues da Cruz


AuthID: R-000-5C6

Confirmed Publications: 291



111
TITLE: Use of botulinum toxin for genitourinary conditions: What is the evidence?  Full Text
AUTHORS: Carlos Martins da Silva ; Michael B Chancellor; Christopher Patrick Smith; Francisco Cruz ;
PUBLISHED: 2015, SOURCE: TOXICON, VOLUME: 107
INDEXED IN: Scopus WOS CrossRef: 9
IN MY: ORCID | CIÊNCIAVITAE
112
TITLE: Biomarkers in lower urinary tract symptoms/overactive bladder: a critical overview. a critical overview
AUTHORS: Antunes Lopes, T ; Cruz, CD ; Cruz, F ; Sievert, KD;
PUBLISHED: 2014, SOURCE: CURRENT OPINION IN UROLOGY, VOLUME: 24, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID | CIÊNCIAVITAE
113
TITLE: Can serum angiogenin be used to improve the diagnostic performance in prostate cancer screening?
AUTHORS: Francisco Pina; Francisco Botelho; Tiago Lopes ; Ivo Lopes; Gabriela Figueiredo; Raquel Portugal; Ana Ferro; Francisco Cruz ; Henrique Barros ; Nuno Lunet ;
PUBLISHED: 2014, SOURCE: EUROPEAN JOURNAL OF CANCER PREVENTION, VOLUME: 23, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 7
IN MY: ORCID | CIÊNCIAVITAE
114
TITLE: Chapter 5: Clinical Data in Neurogenic Detrusor Overactivity (NDO) and Overactive Bladder (OAB). Clinical efficacy of onabotulinumtoxinA  Full Text
AUTHORS: Francisco Cruz ; Victor Nitti;
PUBLISHED: 2014, SOURCE: NEUROUROLOGY AND URODYNAMICS, VOLUME: 33, ISSUE: SUPPL.3
INDEXED IN: Scopus WOS CrossRef: 33
IN MY: ORCID | CIÊNCIAVITAE
115
116
TITLE: Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?. do we have a standard?
AUTHORS: Silva, J ; Silva, CM ; Cruz, F ;
PUBLISHED: 2014, SOURCE: CURRENT OPINION IN UROLOGY, VOLUME: 24, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 53
IN MY: ORCID | CIÊNCIAVITAE
117
TITLE: Gynecomastia Caused By Bilateral Leydig Cell Tumor
AUTHORS: Joana Menezes Nunes; Elisabete Rodrigues ; Joao Magalhaes; Joao Silva ; Francisco Cruz ; Davide Carvalho ;
PUBLISHED: 2014, SOURCE: ENDOCRINE REVIEWS, VOLUME: 35, ISSUE: 3
INDEXED IN: WOS
118
119
TITLE: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology (vol 30, pg 819, 2013)  Full Text
AUTHORS: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLISHED: 2014, SOURCE: ADVANCES IN THERAPY, VOLUME: 31, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID | CIÊNCIAVITAE
120
TITLE: Targets for Botulinum Toxin in the Lower Urinary Tract. Targets for Botulinum Toxin  Full Text
AUTHORS: Cruz, F ;
PUBLISHED: 2014, SOURCE: NEUROUROLOGY AND URODYNAMICS, VOLUME: 33, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 63
IN MY: ORCID | CIÊNCIAVITAE
Page 12 of 30. Total results: 291.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service